advanced search
Dr Marie-Christine Klein
Head of Development & Regulatory Affairs
URSATEC

Is this your profile?

About

Marie-Christine Klein, PhD, is a biologist by training and joined URSATEC in 2019. She is head of the Development & Regulatory Affairs team, which focuses on innovative developments in combination with the URSATEC application technology. Dr Klein is also a founding member of the URSATEC multidisciplinary sustainability team, whose goal is the establishment of a systematic approach for URSATEC’s sustainability strategy.

Contributions

SUSTAINABILITY
TOWARDS A COMPREHENSIVE SUSTAINABILITY STRATEGY
Marie-Christine Klein and Christian Weyler, look at the evolution of the company’s sustainability strategy within its regulatory and economic framework – and what decarbonisation means for the pharmaceutical industry.

More contributions

NASAL
CHALLENGES BESIDES DRUG TARGETING – REGULATORY HURDLES FOR MULTIDOSE NASAL SPRAYS
Marie-Christine Klein,  Andreas Bilstein and Rouven Kraus, discuss recent regulatory changes affecting drug-device combination products, using the example of a multidose nasal spray.
PULMONARY
THE APPLICATION DIVERSITY OF METERED PUMP-BASED SOFT MIST DEVICES
Marie-Christine Klein, Andreas Bilstein and Caroline Hoffmann discuss the underlying techniques involved in the use of metered pump-based soft mist devices and their application diversity.
SKIN
“PRESERVATIVE FREE” – THE SKIN MICROBIOME’S CLOSE FRIEND
Marie-Christine Klein, Andreas Bilstein and Julia Krüger discuss the effects of preservatives on the skin microbiome and consider new technologies that minimise the percentage of preserving agents used in cosmetic formulations.
NASAL
NOSE-TO-BRAIN DRUG ADMINISTRATION AND A NOVEL APPROACH WITH AN OLD FAMILIAR
Marie-Christine Klein, Andreas Bilstein and Rouven Kraus look at the advantages of the nose-to-brain route and soft mist nasal sprays for drug administration.
Top